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Currently, the Consortium consists of 23 studies with data on more than 80,000 mother-and-child pairs from across the globe. We are performing systematic searches to identify eligible studies or datasets from the published literature that can be included in our current project.
Via this letter, we would like to invite anyone that has data available (published or unpublished) that match the inclusion criteria (see below) to join this novel consortium and to contribute to advancing ev-
The clinical evidence highlighting the importance of adequate maternal thyroid function during pregnancy for an optimal pregnancy outcome is rapidly accumulating. However, due to large differences across studies regarding study populations and outcomes, it is difficult to generalize all available evidence and to provide evidence-based recommendations. Furthermore, many important clinical questions remain unanswered because single studies are not adequately sized to study small subgroups and clinical threshold effects.
In order to overcome these limitations, we have founded the Consortium on Thyroid and Pregnancy. The goal of this international collaboration is to create a formal platform for cooperation between researchers and cohorts that facilitates highquality studies on the association of gesta-
